Standout Papers

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous... 1987 2026 2000 2013 1.8k
  1. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. (1987)
    James H. Chesebro, Genell L. Knatterud et al. Circulation
  2. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study (2010)
    Karl Swedberg, Michel Komajda et al. The Lancet
  3. Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations (2015)
    Konstantinos Dean Boudoulas, Jeffrey Borer et al. Cardiology
  4. Targeted Anticytokine Therapy in Patients With Chronic Heart Failure (2004)
    Douglas L. Mann, John J.V. McMurray et al. Circulation
  5. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial (2010)
    Michael Böhm, Karl Swedberg et al. The Lancet
  6. Resting Heart Rate in Cardiovascular Disease (2007)
    Kim Fox, Jeffrey Borer et al. Journal of the American College of Cardiology
  7. Real-Time Radionuclide Cineangiography in the Noninvasive Evaluation of Global and Regional Left Ventricular Function at Rest and during Exercise in Patients with Coronary-Artery Disease (1977)
    Jeffrey Borer, Stephen L. Bacharach et al. New England Journal of Medicine
  8. Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout (2018)
    William B. White, Kenneth G. Saag et al. New England Journal of Medicine
  9. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. (1983)
    Richard B. Devereux, Thomas G. Pickering et al. Circulation
  10. Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex (2013)
    Frank Ruschitzka, William T. Abraham et al. New England Journal of Medicine
  11. Meta-Analysis of the Relation of Body Mass Index to All-Cause and Cardiovascular Mortality and Hospitalization in Patients With Chronic Heart Failure (2015)
    Abhishek Sharma, Carl J. Lavie et al. The American Journal of Cardiology

Immediate Impact

68 standout
Sub-graph 1 of 19

Citing Papers

Five-Year Follow-up after Transcatheter Repair of Secondary Mitral Regurgitation
2023 Standout
Gout
2021 Standout
5 intermediate papers

Works of Jeffrey Borer being referenced

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
2018 Standout
Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib**The investigators had full access to the data and complete control over the design, conduct analysis, interpretation, and description of the study. The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or in writing the report. The views expressed are those of the investigators alone.
2003
and 10 more

Author Peers

Author Last Decade Papers Cites
Jeffrey Borer 17245 3801 4171 342 21.3k
Cheuk‐Man Yu 14938 2582 2545 337 18.7k
John E. Sanderson 11976 2667 2693 251 16.8k
Richard J. Rodeheffer 17764 3144 3626 197 23.3k
Torbjørn Omland 13248 2392 2892 326 18.0k
Christian Mueller 16657 5633 6067 502 22.2k
Fred S. Apple 15501 6625 4701 360 22.2k
Mark H. Drazner 14021 1748 3188 233 18.3k
Andrew P. Selwyn 12102 4899 4742 205 18.0k
Walter J. Paulus 15241 3127 2989 220 20.7k
Alan S. Maisel 16246 1558 3352 420 22.6k

All Works

Loading papers...

Rankless by CCL
2026